Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: Potential application in vaccine and therapeutical developments
- 24 September 2009
- journal article
- review article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 0 (0) , 1-4